Zyla Life Sciences Proceeds from Issuance Initial Public Offering
Zyla Life Sciences reported Proceeds from Issuance Initial Public Offering of $53.03 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2015-11-06
- Zyla Life Sciences proceeds from issuance initial public offering for the quarter ending 2014-12-31 was $0.00.
- Zyla Life Sciences proceeds from issuance initial public offering for the quarter ending 2014-09-30 was $0.00.
- Zyla Life Sciences proceeds from issuance initial public offering for the quarter ending 2014-06-30 was -$92.00K.
- Zyla Life Sciences proceeds from issuance initial public offering for the quarter ending 2014-03-31 was $53.12M.
- Zyla Life Sciences proceeds from issuance initial public offering for fiscal 2014 was $53.03M.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | -$92.00K derived: sum of 3 quarters · filed 2015-11-06 | $53.03M 10-K · filed 2015-03-16 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$92.00K derived: sum of 2 quarters · filed 2015-11-06 | $53.03M 10-Q · filed 2015-11-06 | |
| 2014-06-30 | -$92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $53.03M 10-Q · filed 2015-08-07 | ||
| 2014-03-31 | $53.12M 10-Q · filed 2015-05-08 |